Bcl-2-IN-7 is a potent Bcl-2 (B-cell lymphoma-2) inhibitor with antitumor activity against MCF-7, LoVo, HepG2, and A549 cancer cell lines (IC50 = 20.17, 22.64, 45.57, and 51.50 μM, respectively); it induces cell cycle arrest and apoptosis in breast cancer MCF-7 cells by downregulating Bcl-2 expression and upregulating p53, Bax, and caspase-7 mRNA expression.